No Cover Image

Journal article 344 views 43 downloads

Microneedle technology for potential SARS-CoV-2 vaccine delivery

Megan McNamee, Shuyi Wong, Owen Guy Orcid Logo, Sanjiv Sharma Orcid Logo

Expert Opinion on Drug Delivery, Pages: 1 - 16

Swansea University Authors: Megan McNamee, Shuyi Wong, Owen Guy Orcid Logo, Sanjiv Sharma Orcid Logo

  • 63375.pdf

    PDF | Version of Record

    © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.

    Download (2.44MB)

Abstract

IntroductionMicroneedle fabrication was conceptualized in the 1970s as devices for painless transdermal drug delivery. The last two decades have seen considerable research and financial investment in this area with SARS-CoV-2 and other vaccines catalyzing their application to in vivo intradermal vac...

Full description

Published in: Expert Opinion on Drug Delivery
ISSN: 1742-5247 1744-7593
Published: Informa UK Limited
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa63375
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract: IntroductionMicroneedle fabrication was conceptualized in the 1970s as devices for painless transdermal drug delivery. The last two decades have seen considerable research and financial investment in this area with SARS-CoV-2 and other vaccines catalyzing their application to in vivo intradermal vaccine delivery. Microneedle arrays have been fabricated in different shapes, geometries, formats, and out of different materials.Areas coveredThe recent pandemic has offered microneedle platforms the opportunity to be employed as a vehicle for SARS-CoV-2 vaccine administration. Various modes of vaccination delivery and the potential of microneedle array-based vaccines will be presented, with a specific focus placed on recent SARS-CoV-2 research. The advantages of microneedle-based vaccine administration, in addition to the major hurdles to their en masse implementation, will be examined.Expert opinionConsidering the widely acknowledged disadvantages of current vaccine delivery, such as anxiety, pain, and the requirement for professional administration, a large shift in this research sphere is imminent. The SARS-CoV-2 pandemic has catalyzed the development of alternate vaccination platforms, working to avoid the requirement for mass vaccination centers. As microneedle vaccine patches are transitioning through clinical study phases, research will be required to prepare this technology for a more mass production environment.
Keywords: Microneedles, skin, vaccine, pain-free, minimally invasive, SARS-CoV-2, vaccination, vaccine patch, theranostics
College: Faculty of Science and Engineering
Funders: Swansea University
Start Page: 1
End Page: 16